Veradermics Business Segments — General and administrative, excluding personnel expenses increased by 338.9% to $4.61M in Q1 2026 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
A decrease suggests improved operational efficiency, whereas an increase may indicate rising overhead or expansion of corporate infrastructure.
This metric tracks the non-personnel operating costs required to support the company's general business functions, such...
Comparable to G&A overhead expenses reported by other clinical-stage biotech firms.
mane_segment_reportable_segment_general_and_administrative_excluding_personnel_expenses| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | $1.05M | $4.61M |
| QoQ Change | — | +338.9% |
| YoY Change | — | +338.9% |